Interpreting cost-effectiveness in dialysis: can the most expensive be more expensive?

In this issue, Tonelli et al. describe the cost-effectiveness of arteriovenous fistulae (AVF) screening, and conclude that such a program represents “good value for money.” Here, I examine the robustness of this conclusion by considering traditional definitions of acceptable cost-effectiveness and m...

Full description

Saved in:
Bibliographic Details
Published inKidney international Vol. 69; no. 12; pp. 2120 - 2121
Main Author McFarlane, P.A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2006
Elsevier Limited
Subjects
Arteriovenous Shunt, Surgical - adverse effects
Arteriovenous Shunt, Surgical - economics
Constriction, Pathologic - diagnosis
Cost-Benefit Analysis
Health Care Costs
Humans
Mass Screening
Renal Dialysis - economics
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:In this issue, Tonelli et al. describe the cost-effectiveness of arteriovenous fistulae (AVF) screening, and conclude that such a program represents “good value for money.” Here, I examine the robustness of this conclusion by considering traditional definitions of acceptable cost-effectiveness and more pragmatic definitions, which include consideration of the maximum amount that society would be willing to pay for hemodialysis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0085-2538
1523-1755
DOI:10.1038/sj.ki.5001556